Effect of liraglutide on cardiometabolic profile and on bioelectrical impedance analysis in patients with obesity and metabolic syndrome
Insert the needle into the Retatrutide vial at an angle and inject the water gently against the side of the vial
Retatrutide (Retara), a triple GIP/GLP-1/glucagon agonist, produced the highest mean weight loss in clinical trials (24.2% at 48 weeks)
Consult your doctor if these persist or worsen
Consult a qualified healthcare provider before starting any supplement, especially a transdermal botanical patch, if you're on prescription medication for glucose management, diabetes, or any metabolic condition
When your gut bacteria consume these fibers, they produce short-chain fatty acids like butyrate, which also trigger the release of GLP-1